Skip to main content

Table 3 Characteristics and FDG PET/CT scan findings in SSc patients without ILD (n = 14) and with ILD (n = 22)

From: 18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study

 

SSc patients without ILD (n = 14)

SSc patients with ILD (n = 22)

p value

Potential confusion factors

 Sex, female, no. (%)

11 (78.6)

9 (40.9)

0.027

 Age, years, mean ± SD

54.6 ± 14.3

61.3 ± 10.6

0.12

 BMI, kg/m2, mean ± SD

25.6 ± 5.8

25.1 ± 6.0

0.80

 Glycemia, g/L, mean ± SD

1.1 ± 0.3

1.0 ± 0.1

0.35

 Injection-perfusion duration, minutes, mean ± SD

70.3 ± 11.9

75.6 ± 11.9

0.20

Disease characteristics

 Cutaneous subset, limited, no. (%)

8 (57.1)

11 (50.0)

0.68

 Disease duration, no. (%)

  

0.11

  < 2 years

8 (57.1)

6 (27.3)

 

  2–4 years

1 (7.1)

7 (31.8)

  > 4 years

5 (35.7)

9 (40.9)

 Antibody status, no. (%)

  Anti-nuclear

13 (92.9)

21 (95.5)

NA

  Anti-centromere

7 (50.0)

5 (22.7)

0.15

  Anti-topoisomerase I

1 (7.1)

9 (40.9)

0.054

  Anti-RNA polymerase III

1 (7.1)

3 (13.6)

NA

Organ involvement, no. (%)

 Lung

  Current %FVC, mean ± SD

100 ± 10

80 ± 20

0.015

  Current %DLCO, mean ± SD

70 ± 20

50 ± 20

0.002

 Osteoarticular

7 (58.3)

7 (35.0)

0.20

 Muscle

3 (27.3)

3 (23.1)

NA

 Current mRSS, mean ± SD

13.6 ± 13.1

13.9 ± 11.5

0.96

 Gastrointestinal tract

9 (64.3)

15 (68.2)

1.00

 Pulmonary hypertension

3 (21.4)

5 (22.7)

NA

 Calcinosis

2 (14.3)

2 (10.5)

NA

 Telangiectasia

11 (78.6)

11 (52.4)

0.12

 Ulcer digital

3 (21.4)

7 (35.0)

0.47

 Heart

1 (7.1)

5 (22.7)

NA

Current treatments, no. (%)

 Steroids

3 (21.4)

10 (45.5)

0.14

 Immunosuppressive drugs

3 (21.4)

10 (45.5)

0.14

18F-FDG PET/CT scan findings, no (%)

 Lung

  Abnormal interstitial pattern

1 (7.1)

14 (63.6)

<.001

  hv/SUVmax, mean ± SD

1.4 ± 0.8

2.6 ± 0.9

<.001

  s/SUVmax, mean ± SD

9.8 ± 4.1

17.3 ± 6.0

<.001

  s/Intensities, median (IQR)

0.0 (0.0; 0.0)

8.0 (2.0; 12.0)

<.001

 Lymph node

  Mediastinal, abnormal pattern

2 (14.3)

7 (31.8)

0.43

  Hilar, abnormal pattern

2 (14.3)

6 (27.3)

0.44

 Osteoarticular, abnormal pattern

0 (0.0)

1 (4.5)

NA

 Muscle, abnormal pattern

1 (7.1)

2 (9.1)

NA

 Skin, abnormal pattern

1 (7.1)

1 (4.5)

NA

 Esophagus, abnormal pattern

9 (64.3)

17 (77.3)

1.0

  1. BMI body mass index, %FVC forced vital capacity (as % predicted values), %DLCO diffusing capacity for the lung of carbon monoxide (as % predicted values), hv/SUVmax highest value of the SUVmax among the 10 pulmonary SUVmax, IQR interquartile range, SD standard deviation, s/Intensities sum of the 10 pulmonary intensities, s/SUVmax sum of the 10 pulmonary SUVmax, NA not applicable. p value adjusted on BMI = 0.021; p value adjusted on BMI, <.001